RecruitingNCT05001477
Customized TULSA-PRO Ablation Registry
Sponsor
Profound Medical Inc.
Enrollment
1,000 participants
Start Date
Oct 27, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria4
- Male
- \>18 years old
- Candidate for TULSA-PRO treatment
- willing and able to sign the Informed Consent form
Exclusion Criteria1
- None.
Interventions
DEVICETULSA Procedure
Transurethral ultrasound ablation procedure
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05001477
Related Trials
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
NCT060228225 locations
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location